David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. Del Bourgo, Tom Gibbs (investment director,

WhiteLab Genomics a développé une plateforme de simulation dédiée aux thérapies géniques. Elle permettrait d'accélérer la procédure pour les entreprises pharmaceutiques et les biotech, allant jusqu'à trois fois plus vite. La start-up vient de lever 10 millions d'euros pour financer son expansion aux Etats-Unis.   La start-up WhiteLab Genomics annonce ce 13 septembre une levée de fonds de 10 millions d'euros. Le

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. Founded out of Paris in 2019, recent Y Combinator (YC) graduate WhiteLab Genomics provide gene and cell therapy companies with predictive software simulations to expedite the design of gene and cell therapies. Gene therapy, for the uninitiated, is an

Objectif : accompagner les biotech et les medtech dans leur croissance. Quatre startups font d’ores et déjà partie du programme : MabSilico, WhiteLab Genomics, Ose Immunotherapeutics et Caranx.  Le 15 juin 2022, l'Institut Curie et Microsoft ont dévoilé les contours de leur nouveau programme commun baptisé Biotech Scaler Program. Ce dispositif a pour objectif d'accompagner les biotech et les medtech dans leur croissance. Lancement du Biotech Scaler

Dozens of startups in Y Combinator’s Winter 2022 cohort do something that could be described as artificial intelligence. Though the term has lost much of its meaning, it’s still an important part of the tech landscape, and both using it and enabling it are fertile ground for new companies. Here are 14 notable startups from the latest batch.   Whitelab Genomics Founded: 2019 in

We are proud to announce the nomination of WhiteLab Genomics for the Prix Galien Medstartup. About the Galien Foundation: The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation that improves the state of human health. They assist French companies who want to export in North America and North American companies who want to invest in France. Their vision is to catalyze the

Scientific and business leaders will reinforce our expertise as we develop data science and machine learning solutions for genomic medicine. Paris, France – WhiteLab Genomics, a technology development company specialized in engineering data science solutions for the discovery and development of genomic medicine, today announced the expansion of its Scientific and Strategic Advisory Boards.   Dr. Nicole Paulk from the University of California

Les nouvelles technologies sont un enjeu de sécurité sanitaire. La HealthTech était justement au cœur de notre émission « Garage by Widoobiz » en direct depuis le Salon Viva Technology à Paris. Tour de table avec : Guillaume Rozier, fondateur de CovidTracker et Vite Ma Dose, Francois Recorbet CSO de BodyO et David Del Bourgo co-fondateur de WhiteLab Genomics. En savoir plus 

As part of this collaboration, teams from the Accelerator for Technological Research in Genomic Therapies (ART-TG, Inserm US35) and WhiteLab Genomics will use the WhiteLab Genomics CatalystTM platform to generate a database specific to the bioproduction of lentiviral vectors, which will be used to identify the parameters allowing for a significant increase in vector quality as well as their production

De nos jours, chaque entreprise soigne scrupuleusement son image, avec pour but d’attirer le plus possible les consommateurs. C’est notamment le cas de David Del Bourgo, cofondateur de WhiteLab Genomics, en quête de modernité. Pour donner un coup de neuf à sa société, spécialisée dans la recherche scientifique, il a fait appel à un designer pour revoir entièrement le logo,